A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients

Myelodysplastic syndrome (MDS) comprised a heterogeneous group of diseases. The prognosis of patients varies even in the same risk groups. Searching for novel prognostic markers is warranted. Leukemic stem cells (LSCs) are responsible for chemoresistance and relapse in leukemia. Recently, expression...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Blood Adv
Prif Awduron: Wang, Yu-Hung, Lin, Chien-Chin, Yao, Chi-Yuan, Hsu, Chia-Lang, Hou, Hsin-An, Tsai, Cheng-Hong, Chou, Wen-Chien, Tien, Hwei-Fang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2020
Pynciau:
Myeloid Neoplasia
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042996/
https://ncbi.nlm.nih.gov/pubmed/32078680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001185
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg